Efficient bioreduction of 1-(furan-2-yl)ethanone into enantiomerically pure drug precursor by Lactobacillus paracasei BD101
dc.contributor.author | Sahin, Engin | |
dc.date.accessioned | 2024-10-04T18:49:41Z | |
dc.date.available | 2024-10-04T18:49:41Z | |
dc.date.issued | 2023 | |
dc.department | Bayburt Üniversitesi | en_US |
dc.description.abstract | Asymmetric bioreduction catalyzed by biocatalyst have shown considerable potential in the preparation of chiral alcohols. (R)-1-(furan-2-yl)ethanol ((R)-2) can be used precursor in the synthesis of many naturally bioactive piperidine alkaloids such as (-)-Cassine, (-)-Spectaline, (-)-Carnavaline, Prosafrine and (-)-Prosafrinine. Moreover, (R)-2 a key chiral precursor in the production of alpha, beta-unsaturated delta-lactones, which have antifungal, antibiotic, and cytotoxic effects on human tumor cells. However, the synthesis routes of (R)-2 still pose signif-icant challenges in term of unsatisfactory enantiomeric excess (ee) and gram scale synthesis. In this study, Lactobacillus paracasei BD101 biocatalyst from boza, a cereal-based fermented beverage, for the asymmetric bioreduction of the 1-(furan-2-yl)ethanone (1). Following biocatalytic process optimization, (R)-2 was generated with >99% ee and 97% yield. In addition, 9.9 g of 1 was completely converted into (R)-2 on a gram scale (9.78 g, 97% isolated yield) in 48 h. This is the first report about the fabrication of enantiopure (R)-2 in high gram scale using biocatalyst. The optical purity of (R)-2 produced by asymmetric reduction with L paracasei BD101 was also noteworthy since it was the highest documented to date. This study provides an efficient green process for the biocatalytic synthesis of (R)-2. | en_US |
dc.identifier.doi | 10.1016/j.mcat.2023.113037 | |
dc.identifier.issn | 2468-8231 | |
dc.identifier.scopus | 2-s2.0-85149213014 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.mcat.2023.113037 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12403/3255 | |
dc.identifier.volume | 539 | en_US |
dc.identifier.wos | WOS:000949059000001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Molecular Catalysis | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Drug precursor | en_US |
dc.subject | Whole-cell biocatalyst | en_US |
dc.subject | Asymmetric bioreduction | en_US |
dc.subject | Chiral secondary alcohol | en_US |
dc.subject | (R)-1-(furan-2-yl)ethanol | en_US |
dc.title | Efficient bioreduction of 1-(furan-2-yl)ethanone into enantiomerically pure drug precursor by Lactobacillus paracasei BD101 | en_US |
dc.type | Article | en_US |